Sodium Bicarbonate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Sodium Bicarbonate Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 03/01/2017. Reported reason: Discontinuation of the manufacture of the drug
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-6637-14
- Dosage Form
- Injection
- Presentation
- Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14)
- Initial Posting
- 03/01/2017
- Revised Date
Reason
Discontinuation of the manufacture of the drug